Aligos Therapeutics, Inc. Common Stock ALGS
$6.76
+2.81%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $38.50
- Implied Upside
- +469.5%
- Price Target Range
- $20.00 – $50.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-28 | Lake StreetDaniel Brims |
Initiates coverage on | Buy | $45 |
| 2026-05-21 | Cantor FitzgeraldSteve Seedhouse |
Initiates coverage on | Overweight | $20 |
| 2026-03-26 | WestPark Capital |
Initiates coverage on | Buy | $48 |
| 2026-03-19 | JefferiesAnthea Li |
Assumes | Buy | $60 → $48 |
| 2026-03-11 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $50 |
| 2026-01-07 | UBSMichael Yee |
Initiates coverage on | Buy | $20 |
| 2025-09-12 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $50 |
| 2025-08-18 | HC Wainwright & Co.Patrick R. Trucchio |
Assumes | Buy | $50 |
| 2025-03-31 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $70 |
| 2025-03-11 | HC Wainwright & Co.Ed Arce |
Maintains | Buy | $75 → $70 |
| 2024-11-07 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $75 |
| 2024-10-23 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $75 |
| 2024-09-20 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $75 |
| 2024-08-19 | HC Wainwright & Co.Ed Arce |
Initiates coverage on | Buy | $75 |
| 2023-01-17 | Piper SandlerYasmeen Rahimi |
Maintains | Overweight | $75 → $175 |
| 2023-01-06 | Piper SandlerYasmeen Rahimi |
Upgrades | Neutral → Overweight | $50 → $75 |
| 2023-01-06 | JefferiesMichael Yee |
Upgrades | Hold → Buy | $63 → $75 |
| 2022-11-03 | SVB LeerinkRoanna Ruiz |
Maintains | Market perform | $75 → $50 |
| 2022-05-05 | SVB LeerinkRoanna Ruiz |
Downgrades | Outperform → Market perform | $175 → $75 |
| 2022-03-23 | SVB LeerinkRoanna Ruiz |
Maintains | Outperform | $275 → $175 |
| 2022-03-23 | Piper SandlerYasmeen Rahimi |
Downgrades | Overweight → Neutral | $375 → $100 |
| 2022-03-11 | Piper SandlerYasmeen Rahimi |
Maintains | Overweight | $1175 → $375 |
| 2022-03-11 | SVB LeerinkRoanna Ruiz |
Maintains | Outperform | $250 → $275 |
| 2022-02-16 | SVB LeerinkRoanna Ruiz |
Maintains | Outperform | $375 → $250 |
| 2022-01-07 | JP MorganEric Joseph |
Downgrades | Overweight → Neutral | $750 → $300 |
| 2022-01-07 | SVB LeerinkRoanna Ruiz |
Maintains | Outperform | $725 → $375 |
| 2021-09-09 | SVB LeerinkRoanna Ruiz |
Initiates coverage on | Outperform | $725 |
| 2020-11-10 | Jefferies |
Initiates coverage on | Buy | $650 |
| 2020-11-10 | JP MorganEric Joseph |
Initiates coverage on | Overweight | $825 |
| 2020-11-10 | Piper SandlerTyler Van Buren |
Initiates coverage on | Overweight | $875 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $6.76
- Market Cap
- $41.06 million
- 52-Week Range
- $3.98 – $13.69
- Average Volume
- 150K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.